Studies on the size and stability of chlorpromazine hydrochloride nanostructures in aqueous solution

被引:12
|
作者
Tehrani, S [1 ]
Brandstater, N [1 ]
Saito, YD [1 ]
Dea, P [1 ]
机构
[1] Occidental Coll, Dept Chem, Los Angeles, CA 90041 USA
关键词
chlorpromazine; nanostructures; micellization; thermodynamics; fluorescence; DSC;
D O I
10.1016/S0301-4622(01)00226-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mean aggregate number (MAN) of the antipsychotic drug chlorpromazine hydrochloride (CPZ) nanostructure was investigated by fluorescence quenching using 9-methylanthracene (9-MA) as the quencher. The method was designed to take advantage of the intrinsic fluorescent properties of CPZ. The validity of this method was supported by the results obtained for the MAN which was determined to be approximately 37 for a solution of 10 mM CPZ in 0.1 M pH 6.5 phosphate buffer. An increase in the aggregate size with increasing drug concentration confirmed the stepwise aggregation theory of CPZ micelle formation. Differential scanning calorimetry was used to examine the effects of concentration on the thermodynamics of micellization. The enthalpy of demicellization increased with increasing CPZ concentration (5-12 mM), suggesting a greater stability of the aggregates at higher concentrations. At amphiphile concentrations higher than 12 mM, a plateau of approximately 10 kJ/mol was observed as the enthalpy of demicellization. Fluorescence lifetime results revealed a two-component system at low CPZ concentration, while data at amphiphile concentrations higher than 12 mM could not be fitted to either single or multi-component lifetime values, suggesting an increase in dispersity in these nanostructures at higher CPZ concentrations. Temperatures higher than 40 degreesC tend to destabilize the larger micelles, and demicellization was observed after approximately 45 degreesC. Changes in osmotic pressure in the presence of dextrose up to 0.3 M had no significant effect on the size of these micellar nanostructures. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 50 条
  • [1] Calorimetry studies of chlorpromazine hydrochloride in solution
    Saito, YD
    Tehrani, S
    Okamoto, MM
    Chang, HH
    Dea, P
    LANGMUIR, 2000, 16 (16) : 6391 - 6395
  • [2] The temperature dependence of the micellisation of chlorpromazine hydrochloride in aqueous solution
    Pérez-Rodríguez, M
    Varela, LM
    Taboada, P
    Attwood, D
    Mosquera, V
    COLLOID AND POLYMER SCIENCE, 2000, 278 (07) : 706 - 709
  • [3] The temperature dependence of the micellisation of chlorpromazine hydrochloride in aqueous solution
    M. Pérez-Rodríguez
    L. M. Varela
    P. Taboada
    D. Attwood
    V. Mosquera
    Colloid and Polymer Science, 2000, 278 : 706 - 709
  • [4] Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids
    Czarniak, Petra
    Boddy, Michael
    Sunderland, Bruce
    Hughes, Jeff D.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1029 - 1034
  • [5] STABILITY OF COCAINE HYDROCHLORIDE IN AQUEOUS-SOLUTION
    MURRAY, JB
    ALSHOURA, H
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 : P24 - P24
  • [6] STABILITY AND STABILIZATION OF APOMORPHINE HYDROCHLORIDE IN AQUEOUS SOLUTION
    LUNDGREN, P
    LANDERSJO, L
    ACTA PHARMACEUTICA SUECICA, 1970, 7 (02): : 133 - +
  • [7] STABILITY OF AMITRIPTYLINE HYDROCHLORIDE IN A COMMERCIAL AQUEOUS-SOLUTION
    ROMAN, R
    COHEN, EM
    CHRISTY, ME
    HAGERMAN, WB
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (10) : 1329 - 1330
  • [8] NOTE ON THE STABILITY OF MEFLOQUINE HYDROCHLORIDE IN AQUEOUS-SOLUTION
    REBERLISKE, R
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1983, 61 (03): : 525 - 527
  • [9] ACTIVITY MEASUREMENT OF AQUEOUS CHLORPROMAZINE HYDROCHLORIDE SOLUTIONS
    NAKAGAKI, M
    OKADA, S
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1978, 98 (01): : 82 - 88
  • [10] ELECTROCHEMICAL OXIDATION OF CHLORPROMAZINE HYDROCHLORIDE IN AQUEOUS BUFFER
    TAKAMURA, K
    INOUE, S
    KUSU, F
    OTAGIRI, M
    UEKAMA, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1983, 31 (06) : 1821 - 1826